Clinical Trial to Assess Safety and Efficacy of Autologous Cultured Epidermal Grafts Containing Epidermal Stem Cells Genetically Modified in Patients With JEB (HOLOGENE17)
Stopped No patient ongoing (none completed the study). Changes to the viral vector ongoing.
Conditions
- Junctional Epidermolysis Bullosa
Interventions
- OTHER: Transplantation surgery of genetically corrected cultured epidermal autograft (ATMP)
Sponsor
Holostem s.r.l.
Collaborators